In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

LifeScan, Novo Nordisk develop diabetes devices

Executive Summary

Johnson & Johnson subsidiary LifeScan (blood glucose monitoring systems) will work with Novo Nordisk (diabetes therapeutics) in a worldwide collaboration to develop and market diabetes management devices for diabetics administering insulin via daily injections.
Deal Industry
  • In Vitro Diagnostics
    • Glucose Testing
  • Medical Devices
    • Diagnostic Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing
    • Co-Marketing

Related Companies

Advertisement
UsernamePublicRestriction

Register